tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Financial Statements

2,771 Followers

Sarepta Therapeutics Financial Overview

Sarepta Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.157; its P/E ratio is -19.98; Sarepta Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 396.78M$ 331.82M$ 261.24M$ 253.50M$ 235.96M
Gross Profit$ 547.12M$ 331.82M$ 239.00M$ 231.50M$ 205.16M
EBIT$ 45.60M$ -27.95M$ -9.36M$ -519.03M$ -66.86M
EBITDA$ 56.98M$ -17.02M$ 1.43M$ -507.73M-
Net Income Common Stockholders$ -43.22M$ 8.42M$ -23.94M$ -543.41M$ -109.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.68B$ 1.73B$ 1.86B$ 1.88B$ 1.99B
Total Assets$ 3.26B$ 3.11B$ 3.13B$ 3.06B$ 2.95B
Total Debt$ 1.40B$ 1.37B$ 1.36B$ 1.29B$ 1.60B
Net Debt$ -279.39M$ -362.02M$ -496.04M$ -593.85M$ -387.51M
Total Liabilities$ 2.41B$ 2.35B$ 2.38B$ 2.35B$ 3.13B
Stockholders Equity$ 859.34M$ 764.36M$ 741.41M$ 712.75M$ 384.95M
Cash Flow-
Free Cash Flow$ -73.70M$ -155.62M$ -38.14M$ -218.88M$ -100.36M
Operating Cash Flow$ -54.66M$ -114.71M$ -122.23M$ -209.40M$ -92.39M
Investing Cash Flow$ -64.36M$ -210.57M$ 96.63M$ 12.49M$ 9.80M
Financing Cash Flow$ 1.94M$ 15.40M$ 5.86M$ 101.80M$ 10.75M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

Sarepta Therapeutics Debt to Assets

Sarepta Therapeutics Cash Flow

Sarepta Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis